Burton DR - Search Results

1

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.

Gardner MR, Kattenhorn LM, Kondur HR, von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC, Neale ES Jr, Fellinger CH, Joshi VR, Fuchs SP, Martinez-Navio JM, Quinlan BD, Yao AY, Mouquet H, Gorman J, Zhang B, Poignard P, Nussenzweig MC, Burton DR, Kwong PD, Piatak M Jr, Lifson JD, Gao G, Desrosiers RC, Evans DT, Hahn BH, Ploss A, Cannon PM, Seaman MS, Farzan M. Gardner MR, et al. Among authors: burton dr. Nature. 2015 Mar 5;519(7541):87-91. doi: 10.1038/nature14264. Epub 2015 Feb 18. Nature. 2015. PMID: 25707797 Free PMC article.

2

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ. Parren PW, et al. Among authors: burton dr. Immunol Lett. 1997 Jun 1;57(1-3):105-12. doi: 10.1016/s0165-2478(97)00043-6. Immunol Lett. 1997. PMID: 9232434 Corrected and republished. Review.

3

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. Immunol Lett. 1997. PMID: 9271324 Review.

4

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA. Gauduin MC, et al. Among authors: burton dr. Nat Med. 1997 Dec;3(12):1389-93. doi: 10.1038/nm1297-1389. Nat Med. 1997. PMID: 9396610

5

Why do we not have an HIV vaccine and how can we make one?

Burton DR, Moore JP. Burton DR, et al. Nat Med. 1998 May;4(5 Suppl):495-8. doi: 10.1038/nm0598supp-495. Nat Med. 1998. PMID: 9585194 No abstract available.

6

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.

Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR. Sakurai H, et al. Among authors: burton dr. J Virol. 1999 Apr;73(4):2956-62. doi: 10.1128/JVI.73.4.2956-2962.1999. J Virol. 1999. PMID: 10074145 Free PMC article.

7

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Poignard P, et al. Among authors: burton dr. Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6. Immunity. 1999. PMID: 10229186 Free article.

8

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

Burton DR, Parren PW. Burton DR, et al. Nat Med. 2000 Feb;6(2):123-5. doi: 10.1038/72200. Nat Med. 2000. PMID: 10655088

9

Antibodies in human infectious disease.

Parren PW, Poignard P, Ditzel HJ, Williamson RA, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Res. 2000;21(2-3):265-78. doi: 10.1385/IR:21:2-3:265. Immunol Res. 2000. PMID: 10852127 Review.

10

gp120: Biologic aspects of structural features.

Poignard P, Saphire EO, Parren PW, Burton DR. Poignard P, et al. Among authors: burton dr. Annu Rev Immunol. 2001;19:253-74. doi: 10.1146/annurev.immunol.19.1.253. Annu Rev Immunol. 2001. PMID: 11244037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page